04.10.2012 • News • Mergers & Acquisitions (M&A) • pharmaceutical industry

ANI Pharma to List Through Takeover of BioSante

Unlisted ANI Pharmaceuticals Inca, a speciality and generic pharmaceutical company is listing through the purchase of BioSante Pharmaceuticals, another drugmaker, in an all-stock deal.

BioSante will issue stock to ANI shareholders giving ANI stockholders a 53% stake in the combined company.

The combined company will be renamed ANI Pharmaceuticals and be led by the ANI management team, with Arthur Przybyl serving as chief executive officer, the companies said in a joint statement.

Interview

Specialty Chemicals in a Shifting World
Adapting to Tariffs and Strengthening Regional Networks

Specialty Chemicals in a Shifting World

Jennifer Abril, President & CEO of SOCMA, discusses the impact of new tariffs and the importance of regional supply networks in the specialty chemical industry.

Innovation Pitch

The Start-up Platform for Chemistry & Life Sciences
Discover Tomorrow’s Innovators

The Start-up Platform for Chemistry & Life Sciences

CHEManager Innovation Pitch supports innovation in the chemistry and life sciences start-up scene. The platform allows founders, young entrepreneurs, and start-ups to present their companies to the industry.

Top-Feature